Gratus Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,249
Closed -$439K 139
2026
Q1
$439K Sell
1,249
-140
-10% -$49.9K 0.06% 98
2025
Q4
$455K Buy
1,389
+31
+2% +$9.83K 0.06% 95
2025
Q3
$383K Buy
1,358
+2
+0.1% +$580 0.05% 106
2025
Q2
$379K Sell
1,356
-9
-0.7% -$2.55K 0.06% 104
2025
Q1
$425K Buy
1,365
+71
+5% +$21K 0.07% 97
2024
Q4
$337K Buy
1,294
+123
+11% +$36.5K 0.05% 103
2024
Q3
$372K Buy
1,171
+315
+37% +$103K 0.06% 102
2024
Q2
$284K Sell
856
-1
-0.1% -$294 0.05% 113
2024
Q1
$225K Buy
857
+91
+12% +$26.6K 0.04% 127
2023
Q4
$221K Buy
+766
New +$209K 0.04% 126

Other funds holding AMGN

Gratus Wealth Advisors's AMGN Position: Q2 2026 in Review

Gratus Wealth Advisors sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,249 shares — an estimated $439K sold.

Gratus Wealth Advisors first reported a position in AMGN in Q4 2023 and held it in 10 quarters. The position peaked at $455K in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gratus Wealth Advisors reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Gratus Wealth Advisors sold 1,249 Amgen shares in Q2 2026, an estimated $439K.
  • Gratus Wealth Advisors first reported a position in Amgen in Q4 2023 and held it in 10 quarters.
  • Gratus Wealth Advisors's Amgen position peaked at $455K in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gratus Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.